Results 41 to 50 of about 212,880 (258)

The Chronic Migraine Brain: What Have We Learned From Neuroimaging?

Frontiers in Neurology, 2020
Chronic migraine is a highly disabling disease with a great impact on socioeconomic functioning and quality of life of migraine patients. Chronic migraine usually evolves from episodic migraine that gradually increases in attack frequency, supporting the
Massimo Filippi, Massimo Filippi, Massimo Filippi, Roberta Messina, Roberta Messina   +4 more
doaj   +1 more source

Role of Estrogens in Menstrual Migraine

Cells, 2022
Migraine is a major neurological disorder affecting one in nine adults worldwide with a significant impact on health care and socioeconomic systems. Migraine is more prevalent in women than in men, with 17% of all women meeting the diagnostic criteria ...
R. Nappi, L. Tiranini, S. Sacco, Eleonora De Matteis, R. De Icco, C. Tassorelli   +5 more
semanticscholar   +1 more source

Evaluating Treatment Success in CGRP Antibody Prophylaxis: A Retrospective Cohort Study Comparing Monthly Migraine Days, MIDAS Scores, and HIT-6 Scores

Pain and Therapy
Introduction Monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) or its receptor represent a major advance in migraine prevention. However, standardized criteria for assessing treatment response are lacking.
Carl H. Göbel, Axel Heinze, Katja Heinze-Kuhn, Ursula Müller, Anna Cirkel, Hartmut Göbel   +5 more
doaj   +1 more source

Early antiseizure response to cenobamate (200 mg/day) in focal drug-resistant epilepsy: a retrospective single-center analysis

Epilepsy & Behavior Reports
Clinical studies have shown cenobamate (CNB) is effective for treating drug-resistant focal epilepsy. This study examines Polish patients with epilepsy, assessing the efficacy and safety of CNB at 200 mg/day and factors influencing early therapeutic ...
Ewa Czapińska-Ciepiela, Agnieszka Kondak, Monika Kowalczyk, Piotr Czapiński   +3 more
doaj   +1 more source

Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives

Frontiers in Pain Research, 2021
Chronic migraine is a disabling neurological disorder that imposes a considerable burden on individual and socioeconomic outcomes. Chronic migraine is defined as headaches occurring on at least 15 days per month with at least eight of these fulfilling ...
Tiffani J. Mungoven, Luke A. Henderson, Noemi Meylakh   +2 more
doaj   +1 more source

The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice

Headache, 2018
To provide healthcare professionals with updated guidance in the use of novel preventive and acute treatments for migraine in adults.

semanticscholar   +1 more source

Migraine and sleep disorders: a systematic review

The Journal of Headache and Pain, 2020
Migraine and sleep disorders are common and often burdensome chronic conditions with a high prevalence in the general population, and with considerable socio-economic impact and costs.
C. Tiseo, A. Vacca, A. Felbush, T. Filimonova, Annalisa Gai, Tatyana Glazyrina, Irina Anna Hubalek, Ye.N. Marchenko, L. H. Overeem, S. Piroso, A. Tkachev, P. Martelletti, S. Sacco   +12 more
semanticscholar   +1 more source

Disability, quality of life, productivity impairment and employer costs of migraine in the workplace

The Journal of Headache and Pain, 2021
Background Migraine is the leading cause of days lost due to disability in the world among people less than 50 years of age. There is a paucity of evidence on the impact of migraine and other headache disorders and the cost and productivity losses in the
Toshihiko Shimizu, F. Sakai, H. Miyake, T. Sone, Mitsuhiro Sato, Satoshi Tanabe, Yasuhiro Azuma, D. Dodick   +7 more
semanticscholar   +1 more source

Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks

Pain and Therapy
Around 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or medical consultation. This therapeutic principle is established in most countries, regardless of how the healthcare system is otherwise ...
Carl H. Göbel, Axel Heinze, Anna Cirkel, Hartmut Göbel   +3 more
doaj   +1 more source

Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine Used

Vaccines
Background/Objectives: In this ongoing, multicenter, global cohort observational study, phenotypes of headaches after COVID-19 vaccination were directly compared between different vaccines. Methods: Phenotypes of postvaccinal headache were recorded in 18,
Carl Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, Sarah Karstedt, Mascha Morscheck, Lilian Tashiro, Anna Cirkel, Qutyaba Hamid, Rabih Halwani, Mohamad-Hani Temsah, Malte Ziemann, Siegfried Görg, Thomas Münte, Hartmut Göbel   +13 more
doaj   +1 more source